Brege Laura
SEC CIK 1365619 · EDGAR
BoughtSold
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
| 13 | Brege Laura | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 21:06 | 2026-06-10 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | A - Grant | $0.00 | +6,405 | 30.1K | +27% | $0 |
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | M - OptEx | — | +8,107 | 23.2K | +54% | — |
| DM | 2025-09-12 | 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | Dir | S - Sale+OE | $74.40 | -17.0K | 17.2K | -50% | -$1.26M |
| D | 2025-09-12 | 2025-09-11 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | Dir | M - OptEx | $15.00 | +17.0K | 32.7K | +108% | +$255.0K |
| D | 2025-06-13 | 2025-06-11 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | A - Grant | $0.00 | +6,163 | 23.7K | +35% | $0 |
| 2025-06-05 | 2025-06-04 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | S - Sale | $21.78 | -14.4K | 15.1K | -49% | -$314.6K | |
| D | 2025-06-02 | 2025-05-29 | MIRM | Mirum Pharmaceuticals, Inc. | Brege Laura | Dir | M - OptEx | — | +5,703 | 15.7K | +57% | — |
| D | 2025-06-02 | 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | M - OptEx | — | +9,387 | 29.5K | +47% | — |
| 2024-08-19 | 2024-08-16 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | P - Purchase | $12.81 | +1,000 | 17.6K | +6% | +$12.8K | |
| D | 2024-06-13 | 2024-06-12 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | A - Grant | $0.00 | +5,230 | 16.6K | +46% | $0 |
| D | 2024-05-31 | 2024-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | M - OptEx | — | +6,652 | 20.2K | +49% | — |
| D | 2023-06-16 | 2023-06-14 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | A - Grant | $0.00 | +1,775 | 11.3K | +19% | $0 |
| 2023-06-14 | 2023-06-12 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | S - Sale | $24.87 | -4,500 | 13.5K | -25% | -$111.9K | |
| 2023-06-07 | 2023-06-05 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | S - Sale | $38.74 | -600 | 9,547 | -6% | -$23.2K | |
| DM | 2023-06-05 | 2021-06-22+ | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | M - OptEx | — | +18.0K | 18.0K | New | — |
| D | 2023-04-05 | 2023-04-03 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | M - OptEx | $29.90 | +7,000 | 17.1K | +69% | +$209.3K |
| D | 2023-04-05 | 2023-04-03 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | S - Sale+OE | $40.72 | -7,000 | 10.1K | -41% | -$285.0K |
| D | 2023-01-17 | 2023-01-12 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | M - OptEx | $17.01 | +12.5K | 12.5K | New | +$212.6K |
| D | 2023-01-17 | 2023-01-12 | ACAD | ACADIA PHARMACEUTICALS INC | Brege Laura | Dir | S - Sale+OE | $18.25 | -12.5K | 0 | -100% | -$228.1K |
| D | 2022-06-08 | 2022-06-08 | PCRX | Pacira BioSciences, Inc. | Brege Laura | Dir | A - Grant | $0.00 | +1,160 | 10.1K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations